Drug Profile
Research programme: L-amino acid oxidase - APIT Laboratories/Celonic
Alternative Names: APIT; Aplysia punctata ink toxin; ONCAREXLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator APIT Laboratories
- Developer Celonic
- Class Amino acid oxidoreductases
- Mechanism of Action Oxidoreductase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Head and neck cancer; Liver cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Head-and-neck-cancer in Switzerland (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-cancer in Switzerland (Parenteral)
- 20 Jul 2011 Preclinical trials in Head and neck cancer in Switzerland (Parenteral)